Imunon, Inc. — Director's Dealing 2010

Apr 30, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2008-01-19

Reporting Person: Tardugno Michael H (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-01-19	Common Stock	M	33333	—	Acquired	122662	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-01-19	Common Stock Restricted	$0	M	33333	Disposed		Common Stock (33333)	Direct

Footnotes

F1: On January 3, 2007, Mr. Tardugno was awarded 50,000 of restricted stock vesting in three equal installments beginning Janaury 19, 2008. This was properly reported in a Form 4 filed January 4, 2007 as the acquistion of "Derivative Securities". All of the shares have since vested. The Janaury 19, 2010 vesting was previously reported on a Form 4 filed April 15, 2010. The vesting of the remaining 33,333 was not previously reported on Form 4 and the shares of restricted stock have been incorrectly reports as derivative securities in all of Mr. Tardugno's Forms 4 between January 19, 2008 through April 15, 2010. The restricted stock vested as follows: 16,667 on Janaury 19, 2008 and 16,666 on January 19, 2009.

F2: Represents the shares/derivative securities beneficially owned as of the date of this filing, April 30, 2010